Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
US7794704B2 · kind B2 · utility
36Cited by
2References
68Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 24, 2005 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Jun 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment epithelium (RPE) cells and other retinal progenitor cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.